Australian Pharmaceutical Industries Limited

Equities

API

AU000000API4

Australian Pharmaceutical Industries Limited Announces Executive Changes

May 24, 2017 at 09:55 pm EDT

Australian Pharmaceutical Industries Limited announced that Genevieve Joy Ryan (nee Browne) has resigned as alternate company Secretary effective from 25 May 2017 to take up a new appointment with company as its Compliance Manager.

Latest news about Australian Pharmaceutical Industries Limited

Australian Pharmaceutical Industries Limited completed the acquisition of SILK Laser Australia Limited from Wilson Asset Management (International) Pty Limited and others.	Nov. 28	CI
Australian Pharmaceutical Industries Limited completed the acquisition of InstantScripts Pty Ltd from Bailador Technology Investments Limited and others.	23-07-02	CI
Australian Pharmaceutical Industries Limited agreed to acquire InstantScripts Pty Ltd from Bailador Technology Investments Limited and others for approximately AUD 140 million.	23-06-12	CI
Australian Pharmaceutical Industries Limited terminated the process deed to acquire SILK Laser Australia Limited from Wilson Asset Management (International) Pty Limited and others	23-05-31	CI
Australian Pharmaceutical Industries Limited made a offer to acquire SILK Laser Australia Limited from Wilson Asset Management (International) Pty Limited and others for approximately AUD 170 million.	23-04-18	CI
Biome Australia Limited Signs Material Distribution Agreement with Australian Pharmaceutical Industries	22-05-29	CI
Wesfarmers Completes Acquisition of Australian Pharmaceutical Industries	22-03-31	MT
Wesfarmers Limited completed the acquisition of Australian Pharmaceutical Industries Limited from Washington H. Soul Pattinson and Company Limited and others.	22-03-30	CI
Australian Pharmaceutical Industries Limited(ASX:API) dropped from S&P Global BMI Index	22-03-23	CI
Australian Pharmaceutical Industries Limited(ASX:API) dropped from S&P/ASX 300 Index	22-03-23	CI
Australian Pharmaceutical Industries Limited(ASX:API) dropped from S&P/ASX All Ordinaries Index	22-03-23	CI
Australian Pharmaceutical Industries Limited(ASX:API) dropped from S&P/ASX Small Ordinaries Index	22-03-23	CI
Wesfarmers Secures Court Approval to Acquire Australian Pharmaceutical Industries	22-03-22	MT
Australian Pharmaceutical Industries Limited Announces Special Dividend Within the Financial Year 2022, Payment Date Is March 29, 2022	22-03-17	CI
Competition Watchdog Clears Wesfarmers' Acquisition of Australian Pharmaceutical Industries	22-02-10	MT
Transcript : Australian Pharmaceutical Industries Limited - Shareholder/Analyst Call	22-01-19
Australia's Wesfarmers flags lower first-half profit hurt by coronavirus curbs	22-01-16	RE
Australian Shares Recoup Some Losses on Bargain Hunting	22-01-07	MT
Financials, energy stocks lead rebound in Australian shares	22-01-07	RE
Woolworths Withdraws $609 Million Takeover Proposal for Australian Pharmaceutical Industries	22-01-06	MT
Woolworths Withdraws its Proposal to Acquire Australian Pharmaceutical	22-01-06	CI
Australian shares rebound as financials gain, James Hardie sinks	22-01-06	RE
Wesfarmers to buy Australia's API for $547 mln after Woolworths backs out	22-01-06	RE
API Acquisition by Wesfarmers on Track After Woolworths Withdraws	22-01-06	DJ
Woolworths Group Limited cancelled the acquisition of Australian Pharmaceutical Industries Limited from Wesfarmers Limited and others.	22-01-06	CI

Chart Australian Pharmaceutical Industries Limited

Duration

Period

Chart Australian Pharmaceutical Industries Limited

More charts

Company Profile

Australian Pharmaceutical Industries Limited is an Australia-based pharmaceutical distributor, and health and beauty retailer company. The Company's segments include Australia and New Zealand. The Australia segment is engaged in distribution of pharmaceutical, medical, health, beauty and lifestyle products and retail services to pharmacies, the purchase and sale of health, beauty and lifestyle products and services within the retail industry, including cosmetic products and non-invasive procedures. The New Zealand segment manufactures and owns rights for pharmaceutical medicines and consumer toiletries. The Company's brands include Priceline & Priceline Pharmacy, which is a health, beauty and wellbeing retailer; Soul Pattinson Chemist, which is a pharmacy brand; Pharmacist Advice, which offers professional service and advice; Club Premium, which is a club for independent pharmacies, and Pharmacy Best Buys, which offers a catalog program.

Sector

More about the company